NEW YORK--(BUSINESS WIRE)--Please replace the release with the following corrected version due to multiple revisions.
The updated release reads:
BYHEART APPOINTS DENICE TORRES TO BOARD OF DIRECTORS, STRENGTHENING ITS MISSION TO INNOVATE INFANT NUTRITION
ByHeart, the next-generation infant nutrition company, proudly announces the appointment of Denice Torres to its Board of Directors. This strategic addition underscores ByHeart's commitment to advancing innovation to help all parents feel amazing about how they feed their babies, and fostering meaningful growth within the sector. Torres brings a wealth of experience in consumer health, further solidifying ByHeart’s position as a pioneer in the field of infant nutrition.
"We were immediately drawn to Denice's commitment to driving meaningful change in people’s health and wellness, because infant nutrition is where health begins,” said Mia Funt & Ron Belldegrun, Co-Founders of ByHeart. “Her passion for doing better for babies and their parents, alongside her dedication to mentorship and building strong company cultures, aligns perfectly with our mission to pioneer the next generation of infant nutrition and support parents throughout their feeding journey. Denice’s strategic insight will be invaluable as we continue to expand our presence within the space, while maintaining our unwavering commitment to unparalleled nutrition quality, transparency, and innovation for parents."
As the former Chief Strategy and Business Transformation Officer and President of McNeil Consumer Healthcare at Johnson & Johnson, Torres brings over three decades of executive leadership in health and consumer products. She joins ByHeart after being drawn to the company for its leadership and the opportunity to make a significant impact on families and the future of infant nutrition.
"I am honored to join ByHeart's Board of Directors," said Torres. “I understand the challenges parents face when choosing the right baby formula. ByHeart’s commitment to parents and owning the entire supply chain so that they can empower parents with highest quality, certified-clean ingredients and end-to-end transparency is why I joined the board. We’re creating no-compromise solutions for the next generation.“
This appointment comes at a time of significant growth for ByHeart, which has quickly established itself as a leading innovator in infant nutrition, reaching the top 10% of the US Infant Formula Category in less than a year on the market.1 With ByHeart’s science-backed formula and complete control over its end-to-end manufacturing, Torres’ leadership will play a crucial role in guiding the company’s next chapter of strategic growth, where they will continue to redefine a stagnant industry and further raise the standards in infant nutrition.
For more information about ByHeart’s Whole Nutrition Infant Formula, please visit https://byheart.com.
About ByHeart
Founded in 2016, ByHeart is a next-generation infant nutrition company that was built from the ground up to obsessively innovate and improve nutrition on behalf of babies. As one of the only fully integrated, FDA-registered infant formula brands in the U.S., ByHeart is driven by nutritional excellence and uncompromising quality standards. With manufacturing facilities in Pennsylvania, Oregon, and Iowa, the company is committed to handpicking the finest certified-clean ingredients, controlling every step of R&D, and using a closest-to-breast-milk patented protein blend to provide parents with unmatched peace of mind and transparency for their babies. As a result, ByHeart is the only U.S.-made infant formula company to earn all three prestigious certifications from the Clean Label Project. For more information on ByHeart, visit https://byheart.com.
1Circana L13 Wks W.E. 10/6/24
